The SARS-CoV-2 RNA–protein interactome in infected human cells
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
Characterizing the interactions that SARS-CoV-2 viral RNAs make with host cell proteins during infection can improve our understanding of viral RNA functions and the host innate immune response. Using RNA antisense purification and mass spectrometry, we identified up to 104 human proteins that directly and specifically bind to SARS-CoV-2 RNAs in infected human cells. We integrated the SARS-CoV-2 RNA interactome with changes in proteome abundance induced by viral infection and linked interactome proteins to cellular pathways relevant to SARS-CoV-2 infections. We demonstrated by genetic perturbation that cellular nucleic acid-binding protein (CNBP) and La-related protein 1 (LARP1), two of the most strongly enriched viral RNA binders, restrict SARS-CoV-2 replication in infected cells and provide a global map of their direct RNA contact sites. Pharmacological inhibition of three other RNA interactome members, PPIA, ATP1A1, and the ARP2/3 complex, reduced viral replication in two human cell lines. The identification of host dependency factors and defence strategies as presented in this work will improve the design of targeted therapeutics against SARS-CoV-2.
Article activity feed
-
-
SciScore for 10.1101/2020.07.15.204404: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources For protein detection, we used the following primary antibodies: Nucleoprotein – Abcam #ab272852, POP1 – Proteintech #12029-1-AP. POP1suggested: (Proteintech Cat# 12029-1-AP, RRID:AB_2166477)We used the following secondary antibodies: IRDye 800CW Goat anti-Rabbit IgG (H + L) (LI-COR) anti-Rabbit IgGsuggested: NoneIn the meantime, we coupled 100 μl Protein G Dynabeads (Thermo Fisher Scientific) with 10 μg CNBP antibody (Proteintech, 14717-1-AP) or 10 μg IgG antibody (Cell Signaling Technology, 2729) by incubating antibody-bead suspensions 45 minutes at room temperature. CNBPsuggested: (Proteintech Cat# …SciScore for 10.1101/2020.07.15.204404: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources For protein detection, we used the following primary antibodies: Nucleoprotein – Abcam #ab272852, POP1 – Proteintech #12029-1-AP. POP1suggested: (Proteintech Cat# 12029-1-AP, RRID:AB_2166477)We used the following secondary antibodies: IRDye 800CW Goat anti-Rabbit IgG (H + L) (LI-COR) anti-Rabbit IgGsuggested: NoneIn the meantime, we coupled 100 μl Protein G Dynabeads (Thermo Fisher Scientific) with 10 μg CNBP antibody (Proteintech, 14717-1-AP) or 10 μg IgG antibody (Cell Signaling Technology, 2729) by incubating antibody-bead suspensions 45 minutes at room temperature. CNBPsuggested: (Proteintech Cat# 14717-1-AP, RRID:AB_2081548)Experimental Models: Cell Lines Sentences Resources All subsequent manipulation steps were carried out as described in the eCLIP library preparation protocol80, starting with the reverse transcription of recovered RNA fragments. eCLIP: To facilitate eCLIP experiments in SARS-CoV-2 infected HuH-7 cells, we applied the previously described RAP-MS approach to purify all SARS-CoV-2-bound proteins prior to immunoprecipitating individual proteins from this pool. HuH-7suggested: NoneQuantification of ribosomal frameshifting: HEK293 cells were transiently transfected with either the control construct or the frameshifting construct of our dual-color EGFP-mCherry translation reporter outlined in Supplementary Figure 3a. HEK293suggested: CLS Cat# 300192/p777_HEK293, RRID:CVCL_0045)Software and Algorithms Sentences Resources Quantification and identification of peptides and proteins (RAP-MS and proteome): MS/MS spectra were searched on the Spectrum Mill MS Proteomics Workbench against a RefSeq-based sequence database containing 41,457 proteins mapped to the human reference genome (hg38) obtained via the UCSC Table Browser (https://genome.ucsc.edu/cgi-bin/hgTables) on June 29, 2018, with the addition of 13 proteins encoded in the human mitochondrial genome, 264 common laboratory contaminant proteins, 553 human non-canonical small open reading frames, 28 SARS-CoV-2 proteins obtained from RefSeq derived from the original Wuhan-Hu-1 China isolate NC_045512.290, and 23 novel unannotated SARS-CoV-2 ORFs whose translation is supported by ribosome profiling31, yielding a total of 42,337 proteins. UCSC Table Browsersuggested: NoneRefSeqsuggested: (RefSeq, RRID:SCR_003496)We added NuPAGE LDS Sample Buffer (Thermo Fisher Scientifc) and incubated samples for 3 min incubation at 95°C. Thermo Fisher Scientifcsuggested: NoneComputational analyses: Gene set and pathway enrichment analysis: We performed a hypergeometric Gene Ontology (GO) enrichment analysis for the expanded SARS-CoV-2 interactome proteins using the Database for Annotation, Visualization and Integrated Discovery (DAVID) tool (https://david.ncifcrf.gov/tools.jsp) and applying default settings. DAVIDsuggested: (DAVID, RRID:SCR_001881)Genes were ranked based on the product of the log2 fold change and the log10 moderated t-test P value between the SARS-CoV2 treatment and mock treatments. eCLIP and RNA sequencing analysis: Paired-end sequencing reads from (i) eCLIP experiments, or (ii) sequencing of crosslinked RNA fragments following RAP-MS, were trimmed using a custom python script that simultaneously identified the umi-molecular identifier (UMI) associated with each read. pythonsuggested: (IPython, RRID:SCR_001658)Next, we removed PCR duplicates using the UMI-aware deduplication functionality in Picard’s MarkDuplicates. Picard’ssuggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
